Cargando…

Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis

Phospholipidosis, the excessive accumulation of phospholipids within lysosomes, is a pathological response observed following exposure to many drugs across multiple therapeutic groups. A clear mechanistic understanding of the causes and implications of this form of drug toxicity has remained elusive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinkovska-Galcheva, Vania, Treadwell, Taylour, Shillingford, Jonathan M., Lee, Angela, Abe, Akira, Tesmer, John J.G., Shayman, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243516/ https://www.ncbi.nlm.nih.gov/pubmed/34087196 http://dx.doi.org/10.1016/j.jlr.2021.100089

Ejemplares similares

Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase
por: Glukhova, Alisa, et al.
Publicado: (2015)

Determinants of pH profile and acyl chain selectivity in lysosomal phospholipase A(2)
por: Hinkovska-Galcheva, Vania, et al.
Publicado: (2018)

Predicting the mechanism of phospholipidosis
por: Lowe, Robert, et al.
Publicado: (2012)

Voluntary wheel running activates Akt/AMPK/eNOS signaling cascades without improving profound endothelial dysfunction in mice deficient in α-galactosidase A
por: Kang, Justin J., et al.
Publicado: (2019)

Predicting Phospholipidosis Using Machine Learning
por: Lowe, Robert, et al.
Publicado: (2010)

Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data
por: Muehlbacher, Markus, et al.
Publicado: (2012)

Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis
por: Lee, Ji-Young, et al.
Publicado: (2020)

Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1
por: Shillingford, Jonathan M., et al.
Publicado: (2023)

Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs
por: Öhlinger, Kristin, et al.
Publicado: (2020)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
por: Tummino, Tia A., et al.
Publicado: (2021)

Increased Density of the Liver and Amiodarone-Associated Phospholipidosis
por: Kojima, Sunao, et al.
Publicado: (2009)

Zebra Body Formation Due to Drug-Induced Phospholipidosis Observed on Electron Micrographs
por: Kawahara, Hiroshi, et al.
Publicado: (2021)

Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues
por: Rotimi, Solomon O, et al.
Publicado: (2015)

Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis.
por: Antonini, J M, et al.
Publicado: (1994)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease
por: Costa, Rui M., et al.
Publicado: (2013)

Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits
por: Yamagiwa, Yoshinori, et al.
Publicado: (2016)

Case report of progressive renal dysfunction as a consequence of amiodarone-induced phospholipidosis
por: Duineveld, Mirjam D, et al.
Publicado: (2023)

High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis
por: Pradip, Arvind, et al.
Publicado: (2016)

Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis
por: Patel, Aateka, et al.
Publicado: (2019)

Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2
por: Tummino, Tia A., et al.
Publicado: (2021)

Amiodarone Hepatotoxicity with Absent Phospholipidosis and Steatosis: A Case Report and Review of Amiodarone Toxicity in Various Organs
por: Cimic, Adela, et al.
Publicado: (2013)

Post-transplant de-novo renal phospholipidosis in a kidney transplant recipient: Fabry disease or something else?
por: Naseer, Muhammad Saad, et al.
Publicado: (2020)

Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report
por: Wu, Song-Zhao, et al.
Publicado: (2019)

An Autoinhibitory Helix in the C-Terminal Region of Phospholipase C-β Mediates Gα(q) Activation
por: Lyon, Angeline M., et al.
Publicado: (2011)

Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086
por: Giri, S. N., et al.
Publicado: (1993)

Hydroxychloroquine: Acute kidney injury, prolonged QTC interval and renal phospholipidosis following off-label use: case report
Publicado: (2021)

Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism
por: Breiden, Bernadette, et al.
Publicado: (2021)

Guanylyl cyclase sees the light
por: Tesmer, John JG
Publicado: (2008)

PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer’s disease
por: Nackenoff, Alex G., et al.
Publicado: (2021)

LYSOSOMAL PHOSPHOLIPASES A(1) AND A(2) OF NORMAL AND BACILLUS CALMETTE GUERIN-INDUCED ALVEOLAR MACROPHAGES
por: Franson, Richard C., et al.
Publicado: (1973)

Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate
por: Chen, Jacinda, et al.
Publicado: (2023)

TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
por: Zhao, Ben, et al.
Publicado: (2020)

Full-Length Gα(q)–Phospholipase C-β3 Structure Reveals Interfaces of the C-terminal Coiled-Coil Domain
por: Lyon, Angeline M., et al.
Publicado: (2013)

Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
por: Zhitomirsky, Benny, et al.
Publicado: (2017)

G protein–coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias
por: Chen, Qiuyan, et al.
Publicado: (2022)

Crocin lessens desipramine-induced phospholipidosis biomarker levels via targeting oxidative stress- related PI3K/Akt/mTOR signaling pathways in the rat liver
por: Ahmed El-Sheikh, Amal, et al.
Publicado: (2023)

Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C
por: Akbulut, Simge, et al.
Publicado: (2010)

Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition
por: Hraběta, Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_opnmj4tje04if489tsav0gauvp